NEXN

Chr 1ADAR

nexilin F-actin binding protein

Also known as: CDM2M, CMH20, NELIN

This gene encodes a filamentous actin-binding protein essential for maintaining Z line and sarcomere integrity in cardiac muscle and regulating cell migration through cytoskeletal interactions. Mutations cause dilated cardiomyopathy (both autosomal dominant and recessive forms) and hypertrophic cardiomyopathy. The gene shows both autosomal dominant and autosomal recessive inheritance patterns depending on the specific cardiomyopathy subtype.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

Cardiomyopathy, dilated, 1CCMIM #613122
AD
Cardiomyopathy, dilated, 2M, autosomal recessiveMIM #621261
AR
Cardiomyopathy, hypertrophic, 20MIM #613876
AD
UniProtCardiomyopathy, familial hypertrophic, 20
0
Active trials
20
Pubs (1 yr)
38
P/LP submissions
0%
P/LP missense
0.78
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryNEXN
🧬
Gene-Disease Validity (ClinGen)
hypertrophic cardiomyopathy · ADLimited

Limited evidence — not for standalone diagnostic reporting

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
36 unique Pathogenic / Likely Pathogenic· 290 VUS of 500 total submissions
📖
GeneReview available — NEXN
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.78LOEUF
pLI 0.000
Z-score 2.72
OE 0.55 (0.400.78)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
-0.21Z-score
OE missense 1.03 (0.941.13)
354 obs / 343.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.55 (0.400.78)
00.351.4
Missense OE1.03 (0.941.13)
00.61.4
Synonymous OE0.98
01.21.6
LoF obs/exp: 24 / 43.3Missense obs/exp: 354 / 343.1Syn Z: 0.17
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedNEXN-related hypertrophic cardiomyopathyOTHERAD
DN
0.79top 25%
GOF
0.80top 10%
LOF
0.2385th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports dominant-negative. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median · 1 literature citation
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNInjection of an equal amount of wildtype nexilin had no effect on cardiac function or ultrastructure, indicating a dominant-negative effect of the mutant nexilin.PMID:19881492

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic28
Likely Pathogenic8
VUS290
Likely Benign132
Benign10
Conflicting18
28
Pathogenic
8
Likely Pathogenic
290
VUS
132
Likely Benign
10
Benign
18
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
10
0
18
0
28
Likely Pathogenic
6
0
2
0
8
VUS
22
238
26
4
290
Likely Benign
0
6
37
89
132
Benign
0
0
10
0
10
Conflicting
18
Total382449393486

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NEXN · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →